Aer Therapeutics Team
We are led by an experienced management team with an established track record of success in the development of drug-candidates.
Irina Gitlin, PhD
Vice President, Research and Development
Blair Capel
Director of Finance
Rony Nasrallah
Manager, Program Management
Jordan Low
Director of Clinical Operations
Our Focus
Design and development of thiol-saccharides as safe and effective mucolytic agents with favorable properties for inhaled delivery. Utilization of state-of-the art lung imaging and analysis approaches to identify COPD and asthma patients with clinically silent airway mucus plugs and to measure efficacy of thiol-saccharide mucolytics.